Evidence map›Paper›PMID 35764644›Full record

ArticleNature communications2022

Retraction Note: AKT3-mediated IWS1 phosphorylation promotes the proliferation of EGFR-mutant lung adenocarcinomas through cell cycle-regulated U2AF2 RNA splicing.

Georgios I Laliotis, Evangelia Chavdoula, Maria D Paraskevopoulou, Abdul Kaba, Alessandro La Ferlita, Satishkumar Singh, Vollter Anastas, Keith A Nair, Arturo Orlacchio, Vasiliki Taraslia and 10 more

RetractedOpen access · goldAbstract readRetraction Notice
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 3 countries.

Georgios I LaliotisDepartment of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA. glaliot1@jhmi.edu.ORCID 0000-0001-9205-8258
Evangelia ChavdoulaDepartment of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA.
Maria D ParaskevopoulouMolecular Oncology Research Institute, Tufts Medical Center, Boston, MA, USA.
Abdul KabaDepartment of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA.
Alessandro La FerlitaDepartment of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA.
Satishkumar SinghThe Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH, USA.
Vollter AnastasDepartment of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA.ORCID 0000-0001-5078-2838
Keith A NairDepartment of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA.ORCID 0000-0001-6777-456X
Arturo OrlacchioDepartment of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA.
Vasiliki TarasliaMolecular Oncology Research Institute, Tufts Medical Center, Boston, MA, USA.
Ioannis VlachosDIANA-Lab, Hellenic Pasteur Institute, Athens, Greece.
Marina CapeceDepartment of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA.
Artemis HatzigeorgiouDIANA-Lab, Hellenic Pasteur Institute, Athens, Greece.
Dario PalmieriDepartment of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA.
Christos TsatsanisSchool of Medicine, University of Crete, Heraklion, Crete, Greece.
Salvatore AlaimoDepartment of Clinical and Experimental Medicine, Bioinformatics Unit, University of Catania, Catania, Italy.ORCID 0000-0003-4825-7617
Lalit SehgalThe Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH, USA.ORCID 0000-0002-1151-5427
David P CarboneThe Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH, USA.ORCID 0000-0003-3002-1921
Vincenzo CoppolaDepartment of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA.ORCID 0000-0001-6163-1779
Philip N TsichlisDepartment of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA. Philip.tsichlis@osumc.edu.ORCID 0000-0002-5300-0448
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute · USTufts Medical Center · USTufts University · USUniversity of Crete · GRBeth Israel Deaconess Medical Center · USPasteur Hellenic Institute · GRUniversity of Catania · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35764644
PMCPMC9245574
OpenAlexW4283650065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.